Syndax Pharmaceuticals (SNDX) closed the last trading session at $11.01, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35.23 indicates a 220% upside potential.The mean estimate comprises 13 short-term price targets with a standard deviation of $10.34. While the lowest estimate of $17 indicates a 54.4% increase from the current price level, the most optimistic analys ...

Group 1 - Extreme Networks (EXTR) has shown a significant price increase of 26.3% over the past four weeks, with a mean price target of $18.75 indicating a potential upside of 33.8% from the current price of $14.01 [1] - The mean estimate consists of six short-term price targets with a standard deviation of $3.31, suggesting variability in analyst predictions; the lowest estimate is $15 (7.1% increase), while the highest is $22.50 (60.6% increase) [2] - Analysts have shown strong agreement in revising earnings estimates higher, which correlates with potential stock price movements, indicating a positive outlook for EXTR [11][12] Group 2 - The Zacks Consensus Estimate for EXTR's current year earnings has increased by 4.9% over the last 30 days, with two estimates moving higher and no negative revisions [12] - EXTR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside in the near term [13] - While price targets can be misleading, the direction implied by the consensus price target for EXTR appears to be a useful guide for potential price movement [10][13]

Core Viewpoint - Byline Bancorp (BY) shares have increased by 3% recently, closing at $25.76, with analysts suggesting a potential upside of 25.8% based on a mean price target of $32.40 [1][11]. Price Targets and Analyst Estimates - The mean estimate for BY's price comprises five short-term targets with a standard deviation of $2.30, indicating a range of estimates from a low of $29 (12.6% increase) to a high of $34 (32% increase) [2][11]. - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts are optimistic about BY's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with near-term stock price movements [4][11]. - The Zacks Consensus Estimate for the current year has risen by 1.3% over the past month, with two estimates increasing and no negative revisions [12]. Zacks Rank and Investment Potential - BY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential upside in the near term [13].

Shares of CPI Card Group Inc. (PMTS) have gained 1.3% over the past four weeks to close the last trading session at $29.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $37 indicates a potential upside of 27.5%.The mean estimate comprises four short-term price targets with a standard deviation of $2.94. While the lowest estimate of $33 indicates a 13.7% increase from the curr ...